We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

BIOSYNEX

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) which, in their professional version, al... read more Featured Products: More products

Download Mobile App




Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care

By HospiMedica International staff writers
Posted on 10 Apr 2023

A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. More...

The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet.

LabPad Evolution from Biosynex SA (Illkirch-Graffenstaden, France) is a handheld PoC device that healthcare professionals can use to perform multiple lab-quality measurements directly with patients. With its miniature automated microscope built from two CMOS sensors, the LabPad Evolution can carry out blood tests from a single finger prick. The device uses compatible single-use SmartChip tests that are available in two formats: Tsmart and Ksmart, each for different types of testing. Tsmart is intended for coagulation testing as INR, consisting of a microfluidic microcuvette embedding a dried or freeze-dried reagent (dry chemistry) while Ksmart is meant for lateral flow testing based on visual or fluorescent optical measurements. The LabPad Evolution automatically conducts internal quality controls before, during, and after each measurement, and displays an error message if any interference is detected.

LabPad Evolution can operate as a standalone tool, storing up to 1,000 results in its memory, which can be viewed on its screen. Additionally, the LabPad Evolution is fully connected and can transmit results automatically via USB or Bluetooth. It can integrate with information systems for centralized processes such as operator authorization/identification, patient identification, quality controls, and results validation/management. The current available SmartChip tests are for SARS-COV-2 Antigen, SARS-COV-2 Antibody, and TP/INR rapid tests. Future tests will focus on nutrition and cardiac markers.

Related Links:
Biosynex SA


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Portable Digital Floor Scale
DR400C
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The principle of needle-free injection based on the reflection of shock waves through microbubble dynamics (Photo courtesy of Yibo Ma/Kyushu University)

Novel Needle-Free Reagent Injection Method to Reduce Spread of Infectious Diseases

Currently, drug administration for disease treatment and prevention commonly uses injectors with metal needles. However, as the needle directly contacts the patient’s mucus and blood, the use of different... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.